Gamco, Gabelli up stake in Biosite to 10.86%

By Lisa Kerner

Charlotte, N.C., June 5 - Biosite Inc. shareholders led by Gamco Asset Management Inc. and Gabelli Funds, LLC continued to increase their stake in the company with the purchase of 173,241 shares of the company's stock between May 23 and June 1, priced from $91.79 to $91.99.

The investors beneficially own 1,856,275 shares, or 10.86%, of the San Diego-based biomedical company's outstanding stock, according to a schedule 13D filed with the Securities and Exchange Commission.

On May 23, the investors reported a 9.85% stake in Biosite, up from 7.69% reported on May 16.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.